PETV Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 15:55):

Stats
Today's Volume	9 819.00
Average Volume	52 430.00
Market Cap	13.42M
EPS	$0 ( 2024-02-12 )
Next earnings date	( $0 ) 2024-06-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.940
ATR14	$0.0190 (2.38%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Lai John	Buy	150 000	Common Stock
2024-04-01	Lowenthal Garry N	Buy	90 000	Restricted Stock Units
2024-03-08	Lowenthal Garry N	Buy	0
2023-12-29	Martin James Rudolph	Buy	33 898	Stock Option (right to buy)
2023-12-29	Rudelius Robert James	Buy	31 780	Stock Option (right to buy)

INSIDER POWER
-99.80
Last 95 transactions
Buy: 994 862 \| Sell: 633 405 592

PetVivo Holdings, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PetVivo Holdings, Inc. Financials

Annual	2023
Revenue:	$917 162
Gross Profit:	$390 345 (42.56 %)
EPS:	$-0.850

FY	2023
Revenue:	$917 162
Gross Profit:	$390 345 (42.56 %)
EPS:	$-0.850

FY	2022
Revenue:	$115 586
Gross Profit:	$-85 568.00 (-74.03 %)
EPS:	$-0.560

FY	2021
Revenue:	$12 578.00
Gross Profit:	$1 883.00 (14.97 %)
EPS:	$-0.570

Financial Reports:

No articles found.

PetVivo Holdings, Inc.

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.